NCNA — NuCana plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1709626 ·
Last close
$1.47
Market Cap
$6.12M
52W High
$2.39
52W Low
$1.21
ADV30
33,404
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -4,781,000 | -3,865,000 | 27,553,000 | 21,529,000 | 5,186,000 |
| Dec 2025 | 0 | — | -2,843,000 | -2,485,000 | 29,834,000 | 24,251,000 | 5,507,000 |
| Sep 2025 | 0 | — | -3,571,000 | -281,000 | 32,315,000 | 25,249,000 | 6,389,000 |
| Jun 2025 | 0 | — | -11,627,000 | -24,114,000 | 16,218,000 | 8,443,000 | 8,834,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,540,000
Investing CF
$242,000
Financing CF
$24,557,000
CapEx
$-231,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-251,172,000
Inventory
—
Receivables
$3,037,000
ST Investments
—
EBIT TTM
$-22,822,000
Pretax Income TTM
$-31,970,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -20,833,000 | -29,353,000 | 29,834,000 | 5,507,000 | — | -7,467,000 |
| Dec 2024 | 0 | -23,005,000 | -18,997,000 | 14,774,000 | 8,820,000 | — | -19,118,000 |
| Dec 2023 | 0 | -31,125,000 | -27,632,000 | 27,811,000 | 12,924,000 | — | -26,439,000 |
| Dec 2022 | 0 | -43,717,000 | -32,021,000 | 58,254,000 | 19,752,000 | — | -23,158,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-9.43
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | $6.09M | $2.18 | — |
| ACXP | Acurx Pharmaceuticals, Inc. | $6.06M | $1.41 | — |
| PMHS | Polomar Health Services, Inc. | $6.19M | $0.22 | — |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | $6.03M | $0.46 | — |
| KAPA | Kairos Pharma, LTD. | $5.88M | $0.25 | — |
News headlines (Yahoo Finance, 1h cache)
NuCana Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-13 20:01 · Yahoo
NuCana Appoints Ian Webster as Chief Financial Officer
2026-06-01 12:00 · Yahoo
NuCana Reports First Quarter 2026 Financial Results and Provides Business Update
2026-05-14 20:01 · Yahoo
European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading
2026-04-16 15:05 · Yahoo
NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update
2026-03-19 20:01 · Yahoo
European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading
2026-02-24 16:03 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading; Little Changed for the Week
2026-02-06 16:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
2026-02-04 16:13 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading
2026-01-13 16:10 · Yahoo
NuCana Appoints Theresa Bruce as Chief Operating Officer
2026-01-06 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.